Redcliffe Hospital
Redcliffe, Queensland, Australia
General hospital in Redcliffe, Queensland
Anzac Ave, Redcliffe QLD 4020
About Redcliffe Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Australian and New Zealand Intensive Care Research Centre
5
The George Institute
3
Pfizer
2
Bavarian Nordic
1
CSL Limited
1
Gilead Sciences
1
Hoffmann-La Roche
1
Outcome Rea
1
Peter MacCallum Cancer Centre, Australia
1
Queensland Centre for Gynaecological Cancer
1
Regeneron Pharmaceuticals
1
Clinical Trials at Redcliffe Hospital
During the past decade, Redcliffe Hospital conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 6 clinical trials were completed, i.e. on
average, 46.2% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Ig NextGen 10% in Idiopathic Thrombocytopenic Purpura (ITP) Patients
2007-06-01
2008-10-01
Completed
19
Elesclomol (STA-4783) With Paclitaxel Versus Paclitaxel Alone in Melanoma
2007-08-01
2009-06-01
Terminated
630
Coxsackie Virus A21 Administered Intravenously (IV) for Solid Tumour Cancers (PSX-X04)
2008-02-29
2012-01-12
Completed
8
A Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer
2011-11-28
2017-12-15
Completed
1,297
ADjunctive coRticosteroid trEatment iN criticAlly ilL Patients With Septic Shock
2012-06-13
2017-11-20
Completed
3,800
Early Goal-Directed Sedation Compared With Standard Care in Mechanically Ventilated Critically Ill Patients
2013-11-01
2018-12-01
Completed
4,000
The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-03-22
Terminated
16,784
The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-04-03
Terminated
10,564
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Redcliffe Hospital" #1 sponsor was "Australian and New Zealand Intensive Care Research Centre" with 5 trials, followed by "The George Institute" with 3 trials
sponsored, "Pfizer" with 2 trials sponsored, "Bavarian Nordic" with 1 trials sponsored and "CSL Limited"
with 1 trials sponsored. Other sponsors include 6 different institutions and
companies that sponsored additional 16 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Redcliffe Hospital"
#1 collaborator was "National Health and Medical Research Council, Australia" with 6 trials as a collaborator, "Australian and New Zealand Intensive Care Society Clinical Trials Group" with 3 trials as a collaborator, "Medical Research Institute of New Zealand" with 3 trials as a collaborator, "ANZICS Clinical Trials Group" with 2 trials as a collaborator and "Baxter Healthcare Corporation" with 2 trials as a collaborator. Other collaborators include 14 different institutions and companies that were
collaborators in the rest 23 trials.
Clinical Trials Conditions at Redcliffe Hospital
According to Clinical.Site data, the most researched conditions in "Redcliffe Hospital" are
"Bacteremia" (2 trials), "Cardiovascular Disease" (2 trials), "Critical Illness" (2 trials), "Critically Ill" (2 trials) and "Melanoma" (2 trials). Many other conditions were trialed in "Redcliffe Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Redcliffe Hospital
Most popular intervention types in "Redcliffe Hospital" are "Drug" (14 trials), "Other" (5 trials), "Biological" (3 trials), "Behavioral" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "bococizumab (PF-04950615)" (2 trials), "0.9% sodium chloride" (1 trials), "ARB + DMX-200" (1 trials) and "Amoxicillin-clavulanate" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Redcliffe Hospital
The vast majority of trials in "Redcliffe Hospital" are
22 trials for "All" genders and 1 trials for "Male" genders.
Clinical Trials Status at Redcliffe Hospital
Currently, there are NaN active trials in "Redcliffe Hospital".
undefined are not yet recruiting,
4 are recruiting,
3 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 12 completed trials in Redcliffe Hospital,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Redcliffe Hospital, 1 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 11 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 1 trials that are defined as “Not Applicable".